Print

Print


The role of 6R-tetrahydrobiopterin in the nervous system.


In addition to its cofactor activities for aromatic L-amino acid hydroxylases and nitric oxide synthase (NOS), 6R-tetrahydrobiopterin (6R-BH(4)) shows diverse actions on neurons.

Dopamine release from the rat striatum or PC12 cells was stimulated by 6R-BH(4).

The action of 6R-BH(4) was independent of its cofactor activities and stereospecific.

Ca(2+) channels in rat brain and PC12 cells were activated by 6R-BH(4) via cAMP-protein kinase A pathway.

Membrane potential of PC12 cells was deplorized by 6R-BH(4).

Thus, it is assumed that 6R-BH(4) acts on its specific action site (possibly outside of the cell membrane) to stimulate dopamine release by activating Ca(2+) channels.

Apoptosis induced by depletion of serum and nerve growth factor in PC12 cells was prevented by 6R-BH(4).

The cell surviving effect of 6R-BH(4) was also mediated by activation of Ca(2+) channels and cAMP-protein kinase A pathway.

However, since 6R-BH(4) did not activate mitogen activated protein kinase, it did not support neuronal differentiation.

Nitric oxide (NO)-induced cell death was prevented by 6R-BH(4) in PC12 cells.

NOS activity was not changed by exogenous 6R-BH(4), but NO metabolites in culture medium were decreased by 6R-BH(4).

When endogenous 6R-BH(4) was reduced by inhibition of biosynthesis, cell death was induced in PC12 cells.

Superoxide is observed to be generated during autoxidation of 6R-BH(4).

Superoxide producing system mimicked the cell protective action of 6R-BH(4) against NO toxicity.

Thus, it is considered that 6R-BH(4) protects PC12 cells against NO toxicity by generating superoxide during its autoxidation.

These results raised the possibility that 6R-BH(4) is a self-protective factor against NO toxicity in NO producing neurons.

Our findings indicate that 6R-BH(4) regulates neuronal activities in the brain and that 6R-BH(4) can be a promising drug for neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease.


Prog Neurobiol 2000 Jul 1;61(4):415-438
Koshimura K, Murakami Y, Tanaka J, Kato Y
Department of Medicine, Shimane Medical University, 89-1 Enya-cho, Izumo, Japan

PMID: 10727782

http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10727782&dopt=Abstract

janet paterson
53 now / 41 dx / 37 onset
a new voice: http://www.geocities.com/janet313/
613 256 8340 PO Box 171 Almonte Ontario Canada K0A 1A0